| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,132 |
922 |
$833.34 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
293 |
270 |
$327.26 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,793 |
1,581 |
$109.08 |
| 80061 |
Lipid panel |
1,482 |
1,479 |
$0.00 |
| 82540 |
|
350 |
345 |
$0.00 |
| 86703 |
|
443 |
441 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
12 |
$0.00 |
| 3077F |
|
121 |
112 |
$0.00 |
| 99442 |
|
293 |
281 |
$0.00 |
| 3078F |
|
442 |
396 |
$0.00 |
| 90658 |
|
13 |
13 |
$0.00 |
| 84450 |
|
12 |
12 |
$0.00 |
| 82274 |
|
142 |
142 |
$0.00 |
| 3051F |
|
13 |
13 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
37 |
37 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
17 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,461 |
1,385 |
$0.00 |
| 1220F |
|
316 |
309 |
$0.00 |
| 3044F |
|
173 |
172 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
872 |
809 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
356 |
355 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
188 |
185 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,998 |
1,984 |
$0.00 |
| 85027 |
|
744 |
730 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
448 |
441 |
$0.00 |
| 82043 |
|
350 |
345 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,632 |
3,330 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
430 |
420 |
$0.00 |
| 3079F |
|
52 |
51 |
$0.00 |
| 4450F |
|
258 |
243 |
$0.00 |
| 86593 |
|
136 |
135 |
$0.00 |
| 81001 |
|
40 |
39 |
$0.00 |
| 90686 |
|
41 |
40 |
$0.00 |
| 3074F |
|
360 |
327 |
$0.00 |
| 99441 |
|
26 |
24 |
$0.00 |
| 3075F |
|
67 |
63 |
$0.00 |
| 1111F |
|
94 |
84 |
$0.00 |
| 94760 |
|
30 |
27 |
$0.00 |
| 86592 |
|
12 |
12 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
37 |
37 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
18 |
17 |
$0.00 |
| 90656 |
|
16 |
16 |
$0.00 |